Graves' disease from Epstein-Barr virus reactivation
Part of Eyes & vision, Hormones & metabolism, Immune system & allergy, Infections clinical trials.
This trial is looking at whether a common virus (Epstein-Barr) can trigger Graves' disease, a condition that makes your thyroid overactive. By understanding this link, researchers hope to find better ways to treat or prevent the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed Graves' disease diagnosis.
- You cannot have other thyroid problems like subacute thyroiditis or thyroid nodules that make too much hormone.
- You cannot have diabetes, an active infection, a chronic disease, or cancer.
- You must have had blood tests showing your thyroid hormone levels (FT4, FT3, TSH) and thyroid antibodies (TPOAb, TGAb, TRAb).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different treatment plans to see how well they control Graves’ disease and whether it comes back. It may help by identifying which approach works best to prevent relapse.
This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.
This trial is testing a new drug, BHV-1300, to see if it works and is safe for people with Graves' disease. It might be an option if you have active hyperthyroidism (overactive thyroid) caused by Graves' disease and haven't had certain other treatments.
This trial tests a new treatment called BHV-1300 for people with Graves' disease. It aims to see if the drug is safe and works well. If you have Graves' disease confirmed by blood tests, you may be able to join.
This trial tests an investigational drug called IMVT-1402 for people with Graves' disease whose thyroid is still overactive even while taking standard antithyroid medication. The goal is to see if the drug can better control thyroid hormone levels.
This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.
Hear when a new Graves Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.